THE BRITISH PAIN SOCIETY EXPERTISE WHERE IT MATTERS The British Pain Society {A company limited by guarantee) Consolidated Financial Statements Year ended December 2024 3rd Floor Churchill House 35 Red Lion Square London WCIR 4SG Charity Number: 1103260 Registered Charity in Scotland Number: SC039583 Company Number: 5021381
THE BRITISH PAIN SOCIETY CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Page No. Legal and administrative information Report of the Directors and Trustees 2-11 Independent Exa miner's report 12 Consolidated Statement of Fina ncial Activities 13 Consolidated and Charity Balance Sheets 14 Consolidated and Charity Statements of Cash Flow5 15 Notes to the Financia I Statements 16-26
THE BRITISH PAIN SOCIETY LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 31 DECEMBER 2024 Directors I"January-5 June 2024 th 5 June 2024- 31" December 2024 Prof R Knaggs Dr N ColliEhan President Interim Honorary Treasurer Interim Honorary Secretary Dr C Price Vice President Dr R Munglani Vice President Drs Gulati Council Member Dr R Krishnamoorthy Council Member Ms C Manson Council Member Dr D Pang Council Member Dr M Chincholkar Council Membp.r Dr M sinha Council Member Prof. R. Knaggs Dr N. Collighan President Honorary Treasurer MrMHey Mrm. Hey Honorary secretary Dr C. Price Dr. R Munglani Dr. S. Gulati Dr R. Krishnamoorthy Dr D. Pang Dr M. Chincholkar Dr M. Sinha Dr l Jones. Dr S Harrisson Vice President Vice President Council Member Council Member Council Member Council Member Council Member Council Meniber Council Member *Note thut Ms Cmtlnson ended her term os Council Member on 5June 2024 Note thot Dr l Jone5 and Drs Harrisson begon their term on 5 June 2024 Registered Office: Third Floorchurchill House 35 Red Lion Square London WCIR 45G Bankers.. Ba rclays Bank Leicester LE87 2BB Solicitor: Hempsons Sol icitors Hempsons House 40 Villiers Street London WC2N 6NJ Registered Accountant.. Marcus Cridland B.A.IHonsl F.C.A. Scott Vever5 Ltd Chartered Accountants and Registered Auditors 65 East Street Bridport DT6 3LB
THE BRITISH PAIN SOCIErY REPORT OF THE DIREcfoRS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 The British Pain Society Ithe Societyl is the largest multidisciplinary professional organisation in the field of pain in the UK. It comprises doctors. nurses, physiotherapists, scientists, psychologists, occupational therapists, and other healthcare professionals and researchers actively èngaged in the diagnosis and management of pain and in pain research. As of 31, December 2024, there were 662 members. The Society is the British Chapter of the International Association for the Study of Pain IIASPI and is part of the European Federation of IASP Chapters IEFICI. The wholly owned trading subsidiary 'BPS Pain Business Ltd, was established In September 2014 to run trading operations on beha If of the Society. The Directors present their Annual Report and Financial Statements for year ended 31, December 2024. These financial statements comply with the charitable company's Memorandum and Articles of Association and applicable laws and regulations Ithe Charities Act 2011, the Companies Act 2006, the Charities and Trustee I nvestment (Scotlandl Act 2005, regu latioiis 6 a nd 8 of the Charities Accounts Iscotlandl Regulations 2006 and the Charities SORP IFRS 1021 published in October 2019. 1. STRUCTURE, GOVERNANCE AND MANAGEMENT The British Pai n Society is a company limited by guarantee incorporated on 21" Ja nua ry 2004 and is governed by its Memorandum and Articles of Association, along with the Regulations last updated on 7, October 2022. The Direttors are appointed by ballot of the members, except forthe Vice President, Honorary Secretary and Honorary Treasurer who are appointed by the Directors. Any Ordinary or Honorary Member of the Society is entitled to stand for election to the post of Directornrustee. Only Members who have previously served as Trustees of the Pain Society, the British Pain Society, or 35 Board members of either the International Association for the Study of Pain IIASPI or the European Federation of IASP Chapters IEFICI are eligible to stand for the post of President, Vice President, Honorary Secretary or Honorary Treasurer, however, if no person who fa Ils within the eligibility categories is willing to be considered for electioii, Cou ncil may consider a candidate or candidates from the Ordinary and Honorary Members. All new Directorsnrustees are required to u ndertake formal induction train ing. Th is is scheduled to take place just before or after their first Cou ncil Meeting following their appointment. The Counci l of the Society meets at least four times a yea r. All the decisions related to the management of the Society are made by the Council at these meetings. The President sets the Agenda for the Council meeting and takes overall responsibility for the day-to-day ru nning of the Society a long with the Executive Off icers. There is support for the Council from the following Committees and subcommittees.. Scientific Programme Committee, Communications Committee, Expert Patient and Carer Committee (previously named the Patient Voice Committee), Science and Research Committee, Education Committee, and Finance Committee. Until the end of October 2022 the Council has been supported by a Secretariat, including a CEO who led the Secretariat team in the delivery of the Society's objectives a nd projects and contributed to the strategic planning processes of the Society. From November 2022 onwards the society has enlisted the services of an Association Management Com pany to provide Secretariat services to the organisation. The Secretariat deals with the day to day running of the Society, the organisation of the various meetings promoted by the Society and ma naging the membership of the Society. From April 2024, the society employed an Executive Director to lead the Secretariat in the co-creation and delivery of the BPS strategy, and to deliver on the society's objectives and projects. All executive decisions are made by the Council or the Officers, who are the President, the President-elect lif applica blel, the Vice Pre5identlsl lil a pplicablel the Honorary Treasurer, the Honorary Treasurer-elect lif applicable), the Honorary Secretary and the Honorary Secretary-elect lif applica blel and the I mniediate Past President lif applicable), with input f rom the Secretariat.
THE BRITISH PAIN SOCIErY REPORT OF THE DIRECTORS AND TRUSTEE5 FOR THE YEAR ENDED 31 DECEMBER 2024 An Annual General Meeting of the members is held at the time of the Annua I Scientif ic Meeting and was held in 2024 at the Annual Scientific Meeting on 5 June 2024. At the start of 2024 there were twelve Society Special Interest Groups ISIGsl,' Acute Pain, Headache, I nterventional Pain Medicine, Medicolegal, Neuropathic Pain, Pain in Children, Pain Management Programmes, Pain Education, Pa in in Older People, Philosophy & Eth ics, Pain i n Developing Cou ntries and Primary and Community Care. The governance of these groups is established within the Articles and Regulations of the Society. Risk Management The Council has identified areas of risk within the Society and actions that have been taken by Council to minimise or eliminate these. A business continuity plan was underway in 2024 and work to implement the identified activities is underway. The specific areas of risk identified are as follows.. Finonciol probity.. The Directors have established systems of internal control, comprising financial estimates and annual budgets, delegated authorities for operationa I management and segregation of duties, reviews of financial and investment performance and the identification and managemeiit of risks, in accordance with the publication CC8 '1 nternal Fi nancial Controls for Charities" The i nternal controls have been formalised and are set out as Fina nce Procedu res for the Societv. The internal controls a re subject to ongoing assessment and evaluation by the Directors. At least two meetings a year are held to consider financial management and performance in detail. The Honorary Treasurer reports on financial matters to each Council meeting of the Society, comprising Directors and co-opted members. These meeting5 record the formal review and approval of all aspects of finance, internal controls. and accou nts. I n 2024 work continued on improving and sim plifying financial processes and procedures, with an effort to reduce the complexity of the banking set up. A review of wholly owned trading subsidiary'BPS Pain Business Ltd, was undertaken to understand the purpose and va lue of this entity. It was decided to begin closing this entity and manage all trading through the Society. VAT management has been transferred from 'BPS Pain Business Ltd, to 'The British Pain Society, and steps are in progress to close 'BPS Pain Busi ness Ltd, and related accounts. The Society will continue looking towards further prudent investment by spreading risk of funds across additional institutions alongside strea mlin ing financial operations. Membership Retention.- Further work continues in this area as it reflerts wider challenge5 faced by professional organisations. Declining membershi p numbers ha5 Stabilised due to the efforts in 2023 and 2024. We have also taken proactive steps to enhance member engagement, introduce new membership categories including the Early Career and Student membership-and improve the Society's value proposition. These efforts have helped to stabilise membership numbers and retention, and furtherwork continues in this area to ensure sustained growth and engagement and future planning to ensure a younger members are involved in the Society. Secretariat and Operotiont71 Support.. Continuity in the provision of Secretariat su pport is essential to allow the Society to deliver planned activities and meet the obligations to its members. 2024 has provided stability and continuity in secretariat staff, mean ing that all ongoing activities and operations have progre55ed. Strategy.. In 2024, tlie Society undertook significant strategic work to refine its strategic priorities, activities, and future dire.ction. Through a collaborative process involving Trustees. member data, and key stakeholders, we developed a strategic framework that aligns with our commitment to improving pain care and advocacy. A key focus has been on strengthening multidisciplinary collaboration,
THE BRITISH PAIN SOCIETY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 integrating person-centred care, and enhancing long-term growth. This work has informed our ongoing initiatives and will guide the Society's activities in the years ahead, ensuring we continue to deliver meani ngful impact for people living with pa in. Informotion Technology and Data Protection.. The Society has a website with a built-in database in operation. Data protection and antiviral systems are in place,. the data is backed up daily. Compliance with GDPR is assessed regularlyand procedures arein placeto ensure thatthiscompliance is maintained. Health and Safety The board accepts formally and publicly its collective role in providing health and safety leadership in its organisation. Each mem ber of the board accepts their individual role in providing health and safety leadership for their organisation. The board will ensure that all board decisions reflect its hea Ith and safety intentions, as a rticulated in the health and safety pol icy statement. The board recognises its role in engagi ng the artive participation of workers in improving health and safety. The board will ensure that it is kept informed of and alert to, relevant health and safety risk management issues. In view of the Health and Safety Commission recommendations, the board will appoint one of its nu mber to be the 'Health and Safety Director" usua Ily the President. In line with statutory requirements, the society has Public Liability Insurance, the levels of which are reassessed on a regular basis. Involvement with other bodies The Society is a generic stakeholder for NICE (National Institute for Health and Care Excellencel gu idelines. The Society is a generic stakeholder for I nterventional Procedu res and Health Tech nology Assessments for NICE. The Society is a member of the Association of Medical Research Charities (AM RCI. The Society is a generic stakeholder with NHS England Clinical Reference G roups ICRGSI. The Society ha5 representation on the NHS England Clinical Reference Group for Speciali5ed Pain services. A Society member chairs the Healthcare Resource Group working party, with links to the Royal College of Physicians 'Payment by Results, initiative. The Society has reciprocal representation on the Board of the Faculty of Pa in Medicine IFPMI. The Faculty of Pain Medicine of the Royal College of Anaestheti5ts, the Chronic Pain Policy Coalition, the Royal College of Nursing and the I nternational Association for the Study of Pain IIASPI each have one representative who sits on the British Pain Society Council as a co-opted member. The following orga nisations a re also represented at the British Pain Society Council via elected Cou ncil rnembers who are elected a5 individuals, but who have links with the relevant organisations, The Royal Pharmaceutica I Society, and the Physiotherapy Pai n Association, the Royal College of Nursiiig, the Faculty of Pain Medicine, and the Royal College of Gps. The Society has established a positive relationship with the Depa rtment of Health. The Society is a member of the Specialised Healthcare Alliance ISHCAI, via its Council CRG liaison officer. The Society is a member of the Health Conditions in Schools Alliance, via a representative of the Pain in Children Special Interest Group. Pain Concern attended the BPS ASM and released a BPS ASM special of their podcast "Airing Pain" with interview5 from key speakers at the ASM.
THE BRITISH PAIN SOCIETY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 The Society has signed a Memorandum of Understanding with both the American Academy of Pain Medicine and the Canadian Pain Society to ensure communication of each partie5, events and col laboration on projects of m utual benef it. The Society continues to endorse the Flippin Pain and EFIC public health campaigns. 2. OBJEcfivES AND AcfiviTIES The objects as set out i n the Memorandum and Articles for which the Society is established I the Objects I are the advancement of health by raisingthe standard ofthe managementof pain by promotion of education, research, and tra ining. The Directors confirm that they have referred to the Cha rity Commission's general guida nce on public benefit when reviewing the Society's aims and objectives cind in planning future activities. All the activities below are for the public benef it. The main activities undertaken in relation to the objects are to= Provide facilities for the exchange of information, opinions, and experience about pain between active workers in the f ield. Increase awareness of pain prevalence, disability and pain management among healthcare and other professiona Is and the pu bl ic. Promote education and training in pai n management and research into the understanding and relief of pain. Institute or assist in instituting and provide continuing support for pain research. Cause to be written, published, produced, and circulated, and to encourage contributions to and publication and production of, periodicals, journals, books, papers, a bstracts, pam plilets, posters and other document5 a nd films, videos, recorded tapes, and communications including learned journals, mainstream print, broadcast a nd online media and social media platforms. Endow Chairs, Readerships, Scholarships, Fellobvships and Lectu reships at, and provide other su pport to, appropriate institutions to facilitate the conduct of study and research in furtherance of the Objects. Disseminate the useful results of research. Sponsor and hold meetings, symposia, conferences, lectures, classes, seminars, courses, and exhibitions either alone or with others. Encourage and promote the study and research into aspects of pain. The Society offers four bu r5aries/grants that are availa ble to its members: the" Clulow Research Award" the "Patrick Wall I nternational Meetings Bu rsary" The British Pain Society Study Day Bursary" and the '1 nternational Association for the Study of Pain World Congress Bursary" Full details of the awards, including eligi bility and application forms, are availa ble on the Society website. 3. ACHIEVEMENTS AND PERFORMANCE The Society continued to provide an educational pi'ogramme to increase the knowledge of pain management to professionals and lay people within the rem it of the Memoranda and Articles of Association. Tlie Society delivered the following series of meetings and pu blications: Society Meetings/Events The Annual Scientific Meeting 2024 was held between the 3 - 6 June 2024, Nottingham. A Public Outreach activity was incorporated into the event and held at Nottingham Central library, providing information to over 70 members of the public. A webinar on "Placebo Controlled Trials in Surgery and Physica l or Psychological Pain Management" was held on Iojanuary 2024.
THE BRITISH PAIN SOCIETY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 A webinar on "Chronic pain and the menopause/perimenopause" was held on 24 April 2024. Awebinar on"Improving the Management of Children's Pain in Hospital" was held on 11 July 2024. A webinar on "Towards more trustworthy pain research. The ENTRUST-PE framework" was held on 26 September 2024. A webinar on "Music therapy for people with chronic pain" was held on 14 November 2024. SIG Meetings/Events The society held regu lar webinars covering a wide variety of educational topics.. In January 2024 the Philosophy and Ethics SIG held a webinar'The Global Opioid Crises and Why They Matter to U K Clinicians" In February 2024 the Philosophy and Ethics SIG held a webinar "Can creative activities together with social connection be a legitimate part of a self-management plan?" I n March 2024 the Philosophy and Ethics SIG held a webinar "Social prescribing and/or participation in community assets for people living with chronic pain" In April 2024 the Philosophy and Ethics SIG held a webinar"Revisiting pain" In October 2024 the Philosophy and Ethics SIG held a webina r "Acupu ncture for Chronic Pelvic Pain" In November 2024 the Philosophy and Ethics SIG held a webinar "On a Scale of One to Ten.. a personal examination of the language of pain" On 11 March 2024 the Older People SIG held a webinar"POPPY study & CARE75+ study" The Primary and Community Care SIG held a webinar"Prescribing Forum: Pharmacological Management of Neuropathic Pain" on 18 April 2024. The Pain Management Programme SIG held a webinar"Pain management in the communit¢, on 16 May 2024. The Primary and Community Care SIG held a webinar'mind your Flippin, Language" on 20June 2024. The H eadache SIG held a webinar "Diagnosis and treatment and facial pain" on 4 July 2024. The Primary and Community Care SIG held a webinar "Prescribing Forum.. So, should we ever prescribe opioids?" on 18 July 2024. The Primary and Community Care SIG held a webinar"PROMPPTStudy" on 24 October 20?4. The Primary and Community Care SIG held a webinar "Integrating Supportive Self-management within Services- Live Well with Pain" on 21 November 2024. The society SIGS also held educational in-person events: The Primary and Community Care SIG jointly with the Pain management programmes SIG held an in- person study day on 3 June 2024 'Updates on Pain Rehabilitation Practice" The Philosophy & Ethics Society SIG held their Summer Retreat in person 23- 26 Ju ne 2024. Society Publications/Resources The Society continues to provide its quarterly printed Newsletter 'Pain News, free of charge to its members. The Society continues to provide online access to its journ31 'British Journal of Pain, f ree of charge to its members. The Patient Voice Committee {TPVCI renamed themselves to the Expert Patient and Carer Committee. They hosted a session at the ASM to provide an analysis of their Survey conducted in 2022, about pain patients, routes into the Pain Clinic5, the im par.t of COVID-19 on their pain and accessing support through pain services, self-management and the use of communiti, pain tea ms. They also presenttid the results of their 2023 survey on pain medicines. Their presentation highlighted the irnportance of lived experience in research. The BPS contributed to the development of the UK Pain Messages which will be launched in 2024.
THE BRITISH PAIN SOCIErY REPORT OF THE DIREcfoRS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 The BPS contributed to the development and u pdates of n umerous Patient Information Leaflets prepa red by the Faculty of Pain Medicine, including '1 nformation for adult patients prescribed Non-steroidal Anti- Inflammatory Drugs INSAIDS) for the Treatment of Pain,. The BPS actively supported the promotion of 'Pain Awareness, month in September 2024 on the website and all social media, plu5 weekly member emai Is with links to appropriate resources. In collaboration with the Faculty of Pain Medicine, the BPS is actively involved in the development of a credential for advanced practice th rough Health for England IHEEI. The Communications Committee reviewed several publications, which were approved for endorsement bythe BPS. The BPS contributes, supports aid promotes e-PAIN" from e-Learning for Healthcare, which is a multidisciplinary programme based on the International Association for the Study of Pain's recommended multidisciplinary cu rriculum for healthcare professionals learning about pa in management. e-PAI N is a collaboration between The Faculty of Pain Medicine, the British Pain Society and e-Learning for H ealthcare. It is provided by Health Education England. The Society continues to run surveys i n areas of iiiterest across its membership to gather evidence to support projects and activities. All the society's pu blications and patient information leaflets are available to download f ree of charBe from the website. The Society'5 social media presence on Twitter, Blue sky, I nstagram, Facebook and Linkedln continues to grow. In 2024, the Society continued to respond to requests from media for comment. SIG Publications/Reiources The Pain Management Programmes SIG completed a review and launched an update oil Guidelines for Pain Management Programmes for adults. The Pain Management Programmes SIG continues to update the PMP directory. The Acute Pain SIG published a patient publication on Managing pain after surgery. Subsequently it has been tra ns5ated i nto several languages (including Germa n, Dutch, Portuguese, Austra lian Eng5ishl and foi- use in Southern Af rica. The Society approved the a pplication for an Affiliate SIG for the Pa in N urse Network. The Acute Pain SIG started work on a Patient Information Leaflet on prescribing opioids in ari acute setting. The BPS contributed to the update of the Opioids Aware Website led by the Faculty of Pain Medicine. The u pdate will be released in 2025. The BPS contributed to the u pdate of the Recommendations for Epidural Injections led by the Faculty of Pain Medicine. The BPS released Peri-operative pain management in adults.. a multidisciplinary consensus statement from the Association of Anaesthetists and the British Pain Society. The BP5 contributed to and released the UK Pain messages. We will continue to review and update cu rrent guidelines and patient information leaflets. Bursories & Grants The Clulow Award wa5 last awarded in 2021- no award was granted in 2024 but will open in 2025. Information for people offectod by pain The Expert Patient and Carer committee formed the Lived Experience Collective, a diverse network of individuals witli lived experience of pain. The LEC provides valuable insights to support the Britisli Pain Society's work, helping to shape resources, inform advocacy efforts, and strengthen collaboration
THE BRITISH PAIN SOCIErY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 between healthcare professionals and those d irectly affected by pain. This initiative reflects the Society's ongoing com m itment to ensuri ng that the voices of people living with pain are heard and integrated into our activities. The Expert Patient and Carer committee continue to inform on PPIE work and research. The Society also continues to contribute and endorse patient information leatlets with other organisations. 4. FINANCIAL REVIEW Net def icit for the year as shown in the consolidated statement of f inancial resources was £67,66612023: £13,907). The turnover of the trading subsidiary BPS Pain Business Ltd was £30.30012023.' £57,842). After allowing for all related costs, a donation was made to the Society of £13,69912023.' £43,724). The following is a summary of reserves at 31, December 2024: Restritted funds.. Clulow legacy lincludi ng interest) Other grants etc PLC Seminar 116,744 307,028 834 Designated funds.. ASM SIGS 100,334 102,553 General funds.. invested in fixed assets Free reseNes Total 1.181 222,136 850,810 The net SIG funds of £102,553 are designated within the Society accounts to further the activities of the specific SIGS. The Society continues to support its educational activities, including Special Interest Group Conferences and a series of Study Days/Webinars. These meetings may be supported by unconditional educational grant5 or sponsorship f rom various com panies, and for transparency the SIG activities are accounted for separately. Reserve5 The Directors have reviewed the Society's needs for reserves in li ne with the guidance issued by the Charitv Commission and have made the following provision.. to work towards £300,000 in general funds bei ng kept in reserve to cover the ongoing costs of the Society should there be a failure of income. Sustainable f inance5 remain an ongoing priority for the Society, a nd further work 15 needed to maintain and strengthen this position. Cost management has been a significant focus and will be reflected in the 2025 budget. The principal sou rce of funding continues to be membership su bscriptions. However, the Directors have recognised the importance of divers ifying income streams to ensure long-term financial resilience.
THE BRITISH PAIN SOCIETY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 The new Society strategy will set out a framework to explore and develop additional sources of income, includi ng grants, partnerships, educational in itiatives, and fundraising activities, to su pport the Society's mission and reduce reliance on membership fees alone. Going Concern The Directors continue to discuss its finances in detail at Council meetings, with the Executive Officers meeting monthly frequently to discuss financial issues. In line with possible reduced income from the annual conference, and the move of educational events to online, we have also looked at reducing the correspond ing expenditu re. In 2025 the Society will: Review membership structures and benefits to retain current members and attract new ones, including early-career professionals, professionals who a re retired from practice and research, and international affiliates. Launch a sponsorship and partnerships policy to ensure consistent, values-aligned engagement with external funders and collaborators. Review income-generating opportunities, including workshop fees, exhibitor income, and digital content offerings. I nvest in operational efficiency, including financial management systems, to improve transparency, reduce waste, and support data-driven decision-making. These actions reflect the Society's commitment to long-term sustainability and resilience, ensuring that resources a re directed toward its core objectives while safegua rding its futu re. The Directors have confidence that the Society and the trading subsidiary have adequate resources to remain in operation for 12 months after approval of these fi na ncial statement5. 5. PLANS FOR FUTURE PERIODS The Society will carry out its strategic plan and priorities. The Society will continue the project to develop a consensus statement on interdisciplinary working in Inigraine with a grant f rom Pfizer. The British Pain Society's 2025 Annual Scientific Meeting will take place as an in-person event between 3-5 June 2025. There are 3 education workshops taking place pre-ASM covering various topics: Opioids in Clinical Practice (Organised jointly with the Acute Pain SIG and the Pain Nurse Network) Unlock the Future of Pain Management with Lifestyle Medicine: A Transformative Workshop foi. Clin icians o U Itrasound-guided Neck and Shoulder Intervention workshop The society conti nues to expand its range of webinars, with several Special I nterest Groups ISIGSI also running several webinars in 2025.. The role of Patient Education in Recovery from Persistent Pain.- A Neuroscience Perspective Post Surgical Pain what you need to know in 2025 (Joint webinar with the Association of Anaesthetistsl Pain management essentia Is.. What's 'out there, i n terms of education, su pport, resources, and 'training' for people who are experiencing pain? How can basic scient15ts, healthcare professiona Is and patients i n the BPS work together for the advancement of pain care? o I ntegrating supportive 5elf-management into service51i'ointly with Live Well with Painl Neurodiversity and persistent pain
THE BRITISH PAIN SoCIy REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 Clinical Hypnosis Within I ntegrative Oncology Is chronic pain telling us something important about society. The Philosophy & Ethics SIG will commence planning fortheir annual meeting due to take place in June 2025. The Headache 51G will begin planning a study day in October 2025. BPS will expand the cu rrent suite of educational webinars and podcasts using the BPS events calendar and regional champions to ensure health aiid social care professionals stay updated on the latest knowledge and best practices in pain management. BPS will open to receive applications ,'or the Clulow Award in 2025 BPS will develop research priorities in pain management and promote them. BPS is reviewing the introduction of initiatives such as small grants and student prizes to su pport research by early-career professionals. BPS is working towards how best to create a collaborative forum to share best practices, successful quality improvement initiatives, and lessons learned to drive continuous, equity-focused enhancements in pain management. BPS will stablish buddy systems, remote mentorship programs, and peer support networks to offer continuous professional su pport, guidance, and development for those working in pain care. 6. STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS SO far as the Directors are aware, there is no releva nt audit information of which the compa ny'5 auditors are unaware, and each Director has taken all the steps that they ought to have taken as a Director to make themselves aware of aiiy relevant audit information a nd to establish th.at the compaiiy's auditors are aware of that information. 7. STATEMENT OF DIRECTORS, RESPONSIBIUTIES Cornpany law requires the Directors land also its Trustees foi the purposes of Charity lawl to prepare financial statements for each financial year which gives a true and fair view of the state of affairs of the charitable company and of the incoming resou rces and application of resou rces, i ncluding the income and expenditure, of the charitable company during that period. In preparing those financial statement5 the Directors are requ ired to.. Select suitable accounting policies and then apply them consistently. lill Observe the methods and principles in the Charities SORP. liiil Make judgement5 and estimates that are reasonable a nd prudent. livl State whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statement5. Iv) Prepare financial statements op a going concern basis unless it is inappropriate to presume that the companywill continue in business. The Directors are responsible for keeping proper accou nting records which disclose with reasonable accuracy at any time the firiancial position of the charitable company and to enable them to onsure that thefinancial statements comply with the Companie5 Act 2006, the Charities and Trustee Investment (Scotlandl Act 2005 and the Charities Accounts (Scotlandl Regulations 2006 las amended). They are a150 responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. io
THE BRITISH PAIN SOCIETY REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2024 In prepdring this report the Directors have taken adva ntage of special provisions of the Companies Act 2006 relating to small companies. Signed: Dated.. 203 Dr Neil Collighan IHonorary Treasurer) li
THE BRITISH PAIN SOCIErY INDEPENDENT EXAMINER'S REPORTTO THE DIRECTORS FOR THE YEAR ENDED 31 DECEMBER 2024 I report to the charity Tru.5tees on my examination of the accounts of the company for the year ended 31 December 2024, which are set out oli pages 13 to 26. Responsibilities and basis of report A5 the charity Trustees of the company la nd also its Directors for the purposes of company lawl you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 20061'the 2006 Act'l. Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of you r compa ny's accounts as carried out under section 145 of the Cha rities Act 20111'the 2011 Act'l. I n carrying out my examination I have fo15owed the Dirertions given by the Cha rity Commission u nder settion 145151 Ibl of the 2011 Act. Independent examinerfs statement I have completed my examination. I confirm that no matters have come to my atte.ntion in connection with the exan)ination giving me cause to believe that in any material respect.. Accounting records were not kept in respect of the company as required by section 386 of the 2006 Act,. or The accoLI nts do not accord with those records; or The accounts do not comply with the accounting requirements of section 396 of the 2006 Act other thari any requirement that tha accounts give a 'true a nd fair view, which is not a matter cons idered as part of an independent e.xamination- or The acLounts have not been prepared in accordance with the methods ènd principles of the Statement of Recom mended Practice for accounti ng and reporting by charities lapplicable to charities prepari ng their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 10211. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the account5 to be reached. Signed.. Dated.. 251 M J Cridland BA (Honsl FLA Scott Vevers Ltd Chartered Accountant5 & ReE15tered Auditor5 65 East street Bridport Dorset DT6 3LB 12
THE BRITISH PAIN SOCIETY CONSOLIDATED STATEMENT OF FINANCIAL AcfiviTIES (including consolidated income and expenditure account) FOR THE YEAR ENDED 31 DECEMBER 2024 Unrestricted Restricted Funds Funds TOTAL TOTAL 2023 Notes 2024 Income from: Donations and legacies 111,630 111,630 118,440 Income f rom charitable activities 33,939 33,939 40,580 Incomefrom other trading octivities Commercial trading operation5 30,300 30,300 57,842 Investment income-intiirest received 17,828 17,828 18,332 Total income 193,697 193,697 235,194 Expenditure on. Roising Fund5 Commercial trading operations 4,581 4,581 5,100 Charitable activities 256,782 :)6,782 244,001 Total Expenditure 261,363 261.,363 249,101 Net income/lexpenditurel for the year (67,666) (67,666) (13,907) Gross transfers between funds Net movement in funds (67,666) (67,666) (13,907) Reconciliation of funds- Total Funds at ljanuary 2024 493,870 424,606 918,476 932,383 Total Funds at 31 December 2024 426,204 424,606 850,810 918,476 All amounts derive frorn contiriuinB activities. All Eains and losse5 recognised in the period are included in the statement of financial activities. The notes on pages 16 to 26 form part of these tinancial staiements 13
Cornpany Registration Nufnber.. 5021381 (England Walesl THE BRITISH PAIN SOCIETY BALANCE SHEETS AS AT 31 DECEMBER 2024 Consolidated 2023 Charity Note 2024 2024 2023 Fixed a55ets Tangible assets Investments 12 13 1,181 1,879 1,181 1,879 1,181 1,879 1,182 1,880 Current assets Debtors Cash at bank and in hand 14 4,606 960,521 15,265 1,063,405 14,168 948,498 89,287 985,699 Total current assets 965,127 1,078,670 962,666 1,074,986 Creditors: amounts falling due within one year 15 (115,498) (162,073) (114,138) (159,490) Net Current assets 849,629 916,597 848,528 915,496 Net assets 850,810 9l8,476 849,710 917,376 Funds of the charity Restricted iiicotTie funds 16 424,606 424,606 42a 606 4?4,606 unre.stricted incomefunds.. Designated funds General funds 202,887 223,317 426,204 242,956 250,914 493,870 202,887 222,217 4£.5,104 ?42,q56 249,814 492,770 Total charity funds 850,810 918,476 849,710 917,376 The Directors have preparp.d group accounts in accordance with section 398 of the Companies Act 2006, tlie Charities ALt 2011 and seLtion 44 of the Charities and Trustee Investment Isrotlandl Act 2005. These account) are. prepared in accordance with the special provisions of Part 15 of the colp ies p.ct relating to small companies. For the financial year in question. the coinpany is entitled to exemption from audit under Section 477 of the Companies Act 2006 relatiig to sniall companies. Tlie members have not required the compaiiy to obtain a17 audit of its financial Statements for the ¥ear iii questiori in accordarice witli Section 476 of tlle Conipanief Act 2006. The Directors acknowledge their responsibilities for com plying with the requirenient5 of tlie Companies Act 2006 with respect to accounting records and the preparatioii of ac.counts. The finaiicial statements wei'e approved by the Directors on Signed or, their behalf by Dr N Collighan- Honordry Treasurpr Tne notes on page.s 16 to 26 form part of these financi31 stit teiTpiits 14
THE BRITISH PAIN SOCIETY STATEMENT OF CASH FLOWS AND CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 Consolidated 2024 2023 Charity 2024 2023 Net cash flow from operating activities 1120,7121 13,270 155.0291 145,4011 Cash flow from investing activities Interest received 17,828 18,332 17,828 18,332 Net cash flow from investing activities 17,828 18,332 17,828 18,332 Cash flows from financing artivities Net increase/ldecrease) in cash and cash equivalents 1102,8841 31,602 137,2011 127,0691 Cash and cash equivalents at l January 2024 1,063,405 1,031,803 985,699 1,012,768 Cash and cash equivalents at 31 December 2024 960,521 1,063,405 948,498 985,699 The notes uii pages lty to 26 form part of these financial statements 15
THE BRITISH PAIN SOCIErY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 l General information The Charity is a company limited by guarantee incorporated in England and Wales under the Companies Act 2006 and Charities Act 2011. The address of the registered office is provided in legal and administrative details. Details of the Charitrfs operations are provided in the Report of the Directors. The lia bility in respect of the guarantee is limited to £1 per member of the Charitv. 2 Accounting policies The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparatioii of the financial statements are as follows.. a) Basis of preparation The financial statements b.a4e been prepared in accordance with Accounting and Reporting by Charities Statement of Recommended Practice applicable to charities prepariiig their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021- (Charities SORP IFRS 10211, the Charities Act 2011, section 44 of the Chtirities and Trustee Investment (Scotlandl Act 2005 and the Companies Act 2006. The British Pain Society meets the definition of a public benef it entity under FR5 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant policy note. b) Accountlng convention The financial statements have been prepared on a going concern basis as the Trustees believe that no material uncertainties exist. The Trustees have considered the Sevel of funds held a nd the expected level of incoine and expenditure for 12 months from authorising these fiiiancial statements. The budgeted income and expenditure is sufficient with the level of reserves for the Chai'ity to be able to continue as a going concern. c) Basis of consolidation The financial statements consolidate the results of the Charity and its wholly owned subsidiary BPS Pain. Business Ltd on a line by line basis. The accounting year ends are coterm inous. The parent Chai'ity has taken advantage of section 408 of the Companies Act 2006 not to include an individual income aiid expenditure of its results. d) Income All incoming resource5 are included on the Statement of Financial Activities when the Charity is legally entitled to the income, it is probable the income wil I be received and the amount can be quantified with reasonable accuracy. Membership subscription periods commence on 1st November each year and therefore the recognition of subscription iiicome received in advance is deferred. Interest on funds held on deposlt is included when receivable and the amount can be measured reliably by the Charity. el Donated services and facilities Donated professional service5 and donated facilitie5 are recognised as income when the Charity has control over the item, ariy conditions associated with the donated item have been met, the receipt of economic benefit from the use by the Charity of the item 15 probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FR5 1021, general volunteer time is not recognised. Inforination on the contribution of Directors is given in the annual report. On receipt, donated professional services and donrlted facilities are recognised on the basis of the value of the gift to the Charityi which is the amount the Charity would have been willing to pay to obtain services or facilities of equivalent ecoiiomic benefit on the open market; a corresi)onding amount is then recognised in expenditure in the period of receipt. 16
THE BRITISH PAIN SOCIETY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2 Accounting policies (continued) f) Expenditure Expenditure is accounted for on an accruals basis aiid has been classified under heading5 that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. gl Fund accounting Unrestricted funds are available to spend on activities that further any purposes of the Charity. Designated funds are unrestricted funds of the Charity which the Trustees have decided at their discretion to set aside to use for a specific purpose. Restricted funds are doiiations which the donor has specif led are to be solely used for particular areas of the Society's work or for specific projects being undertaken by the Society. Further explanation OF the nature dnd purpose of each fund is included in the notes to the financidl statements. h) Tangib5e fixed assets Tangible fixed assets are stated at cost le55 depreciation. Assets costing less than £500 are written off in the yedr of purchase. Depreciation 15 provided at the following annual rate5 in order to write off each asset over its estimated usefu5 life as folluws.. Office Equipment - 5 years straight line Fixtures and Fittings 5 years straight line Change in Accounting Pollcy- Depreciation rate During the year, the Charity reviewed the pattern of consumption of economic benefits associated with its tangible fixed assets. As a result, the Charity chaiiged the depreciation method applied to the asset from 25°A reducing balance metho(1 to 5 vears straight line method. The Trustees consider that depreciating the assets over 5 years reflects the expected usage pattern and future economic benefits of the asseis. This change in accounting policy ha5 been applied prospectiveSy from l January 2024 in accordance with FRS 102 Section 10.16. The impact of the change in the current financial year 'Nas a dpcrease in depreciatian expense of £81 and assets with the net book value of £403 being written off. Prior period figures have not been restated. l) Operating leases Rental charges payable under operating leases are charged on a straight line basis over the terms of the lease. j} Financial instruments Classification Financial assets and financial liabilities are recognised when the Charity becomes a party to the contractual provision5 of the instrument. Financial liabilities and equity instruments are cla55ifie,d according to the substance of the contractual arrangement entered into. An equity instrument is any contract that evidences a residual interest in the asset5 of the Chhrity after dedLlCting all of it5 liabilitie5. Recognition and measurement All financial assets and liabilities are initially measured at transaction price lincluding transaction costsl, except for those financial assets classified as at fair value through profit or105s, which are initially measured at fair value Iwhich is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transactions. If an arrangemeyt constitutes a financing transaction, the financial asset or financial liability Is measured at the present value of the future payments discounted at a market rate of interest for similar debt instrumeiit.5. Financial a55ets and liabilities are orily offset in the Statement of financial position when, and only when there exists a legally enforceable right to set off the rei:ognised amounts and the Charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneousl'¢. 17
THE BRITISH PAIN SOCIEri NOTE5 TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policles {continuedl j) Financial instruments Financial assets are derecognised when and only when al the contractual rights to the cash f lows from the financial asset expire or are settled, bl the Charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or cl the Charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party. Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires. Financlal performance of the Charity A summary performance of the Charity excluding the results of its wholly owned subsidiary is: 2024 2023 163,397 12,020 13,699 189,116 256,782 (67,666) 177,352 6,550 43,724 227,626 244,001 (16,375) Incoming resou rces Income from subsidiary company paid under licence Donation of profits under gift aid Expenditure on charitable activities Net expenditure 4 Income from donations and legacies 2024 2023 2,604 109,026 111,630 583 117,857 Donations Subscriptions Income f rom charitable artivities 2024 2023 16,680 17,259 33,939 26,720 13,860 40,580 SIGS Other income including royalties 18
THE BRITISH PAIN SOCIETY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Other trading activities - BPS Pain Busine55 Ltd 2024 2023 Income generated by BPS Pain Business Ltd 30,300 57,842 BPS Pain Business Ltd Iregistered in Engla nd and Wales, com pany no. 92200781 is the Charity's wholly owned subsidiary. It operates the trade exhibition at the anriual scientific meeting, and other trading activities, under licence from the Charity. The results of the company for the year were as follows-_ 2024 2023 Turnover Cost of sales and administration costs Costs recharged by the Charity under licence Profit Donation under gift aid to The British Pain Society Retained in subsidiary Aggregate assets 30,300 {2,177) (14,424) 13,699 (13,699) 57,842 (5,100) (6,550) 46,192 (43,724) 2,468 I,ioi I,ioi 19
THE BRITISH PAIN SOCIETY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Expenditure on charitable activitie5 2024 2023 Staff costs Direct costs Support costs Governance costs 195 124,810 107,365 11,631 244,001 201,432 49,265 6,085 256,782 2024 2023 Direct costS.- Research grants ASM costs Other meeting costs Newsletter and Journal iioi 10,030 71,061 43,729 124,810 37,342 126,880 37,210 201,432 Support C05ts.' Property costs Office costs C.ompute." 5ySteni and software Insurance Doubtful deb4S Accountancv Depreciation Loss on disposal of asset5 Legal and professional fees 24,097 16,561 1,143 466 66,847 15,053 5,032 3,001 12, 1861 9,355 469 1,360 8,434 107,365 295 403 6.300 49,26) Governance costs.. Council expense5 Induction and training of Trustees Indeppiident exam ination Annual report 3,716 60 2,295 14 6.085 8,919 2,712 11.631 Net income/(expenditure) for the year This is stated after charging.. 2024 2023 Depreciation Operating lease payment5 Independeilt Examiner's remuneration.. Accountancy Services Independent Exarnination Fees 295 469 12,959 15,000 1,355 940 1,592 I,l20 20
THE BRITISH PAIN SOCIFri NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 9 Grant5 The attached annual report details the grants offered by the Charity. The Clulow Award: The award is awarded bi-annually lup to a maximum of £50,000), and is paid in four instalments at agreed milestones. The first three instalments will be paid at 30°A of the total invoice from the receiving institution. The first In5talment will be transferred following receipt of the signed grant value and the foijrth at IO°A, each against an award letter. The second and third instalments will be paid on receipt and approval by The British Pain Society of two progress reports to be subm itted at 12 and 18 months from the date of receipt of grant award letter. A final instalment of IO% will be paid upon receipt of the study final report. Patrick Ivall International Meetings Bursarv.. The Society has made funds available to assist scientists, clinical or allied hea5th practitioners at the earlv stages of their careef in pain research who require financial assistance to present their work at overseas scientific meetings, other tPian the British Pain Society's Annual Scientific Meeting and the IASP World Congress (separate bursaries are available for these two meetings). The Pfizer grant.. The grant was received to support a projett intended to promote interdisciplinary working in the assessment and treattTient of migraine. The aim is to look at ways to improve treatment for people suffering with migraine by providing timely access to specialists to have a diagnosis and a pei"sonalised rnanagemLJnt plan which could be implemented through other primary and secondary care services. 2024 2023 Clulow award cost.. (io) (io) Total grants and bursarie5 awarded.. During the year this event was wholly outsourced to Kenes International Organizei-s of Congresses SA. A summary performance of the annual conference.. 2024 2023 Incoming resources Expenditure incurred Net income / (expenditure} 262,791 268,284 (5,493) 268,100 245,114 22,986 The Society also had direct Annual Scientific Meeting activity in the year which is sumniarised on note 16. 10 Analysis of Staff costs and council expense5 No Charity trustee received a salary, benefits or any other payment for services supplied to the Charity12023'. 6 Trustees were reimbursed expenses, including those of attending the A5M during the year of £2,43612023: 13 Trustee5 £6,080). The total cost of runniiig the council excluding ASM c05t5 was as follows.. 2024 2023 Meetiri8- Room Hire / Catering Meeting Travelling 964 2,752 3,716 2,373 4,042 6,415 21
THE BRITISH PAIN SOCIE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 11 Corporation tax The Charity is exempt from tax on income and gain5 falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. 12 Tangible fixed assets (Group and Charity) Office Equipment Fixtures & Fittings Total Cost.. As at lJanLiary 2024 Disposals As at 31 December 2024 3,540 (1,744) 1,796 8,214 (6,721) 1,493 11,754 {8,465) 3,289 Depreciation: As at l January 2024 Charge for the year Disposals As at 31 December 2024 2,428 112 (1,496) 1,104 7,447 123 (6,566) 1,004 9,875 295 (8,062) 2,108 Net book value: As ar 31 Derember 2024 692 4813 1,181 As at 31 DLcember L023 761 1,879 13 Flxed asset Investment Group Charity 2024 2023 2024 Wnolly Ovoned subsidiary BPS Pain Bus5ness Ltd= l ordinary share of £1 14 Debtors Group Charity 2024 2023 2024 2023 Operational invoices Amounts owed by gi'oup undertakings Prepayments Other dehtors 7,80U 9,562 3,982 624 81,822 4,363 3,102 89,287 3,982 624 4,363 3,102 4,606 14,168 22
THE BRITISH PAIN SOCIErf NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 15 Creditors: amount5 falling due within one year Group Charity 2024 2023 2024 2023 Trade creditors Subscriptions advanced payments Other creditors Accruals for grants payable Accruals Taxation and VAT 1,798 83,942 234 19,855 4,289 5,380 115,498 47,377 73,800 4,564 30,000 6,250 82 1,798 83,942 234 19,855 2,929 5,380 114,138 45,936 73,800 4,564 30,000 5,190 162,073 159,490 16 Analysis of charitable funds Net Balance 01.01.24 31.12.24 Income Expenditure income Transfers 2024 Restricted funds Clulow legacv Graiits PLC Seiyiiriar 116,7 307,028 834 116,744 307,028 834 424,606 424,606 Designatpd funds SIGS Map of Iv1edicine Pathways ASM 16,680 (11,633) 5,047 97,506 7,7/4 137,676 242,956 102,553 (7,774) (37,342) (48,975) (37,342) (32,295) 100,334 202,887 16,680 (7,774) General fund 146,717 (207,807) 163,397 (256,782) (61,090) (93,385) 33,493 249,814 222,217 849,710 Total éunds of the Charity 25,719 917,376 BPS Pain Business Ltd 30,300 (4,581) 1261,3631 25,719 167,6661 (25,719) I,ioo I,ioo Total funds 193,697 918,476 850,810 23
THE BRITISH PAIN SOCIETY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 16 Analysis of charitable Aund5 (continued) Net income Balance 01.01.23 31.12.23 Income Expenditure Tran5fer5 2023 Restrictedfunds Clulow legacy Gronts PLCSeminar io io 116 734 307,028 834 116 744 307,028 834 io io 424,596 424,606 Designutedfund5 SIGS Mop of Medicine Pothways ASM 47,489 (23,968) 23,521 [17,588) 91,573 7,774 145,952 97,506 7,774 137,676 (8,276) (32,244) [8,276) 15,245 47,489 (17,588) 245,299 242,956 Generolfund Totolfunds of the Chority 129,863 (211,767) 177,352 (244,001) (81,904) (66,649) 67,862 50,274 263,856 933,751 249,814 9J7,376 BPS Pain 811siness Ltd 57,842 (5,100) 235,194 (249,101) 52,742 (13,907) (50,274) (1,368) 932,383 I,ioo 918,476 Totalfund5 Details of restricted funds Clulow Legacv A legacy was received from Mildred B and Elaine Clulow for '8asic research into the causes and cures for pain Grants In 200812009 grants were received from industry to support the development of d Primary Care initiative to produce a range of GP/primary care resources. In 2022 8 grant was received from Pfizer to support a projert intended to promote interdisciplinary workiiiE in the assessment and treatment of Migraine. PLCSeminar In 2016 a restricted grant for the work of the Patient Liaison Committee was received. In auTreement with the funder, the grant was agreed to be used to support the provision of an annual 'Professor Sir Michael Bond Lecture, aimed at topics relevant to people living with pain. Details of designated f unds SIGS The Directors have set aside the accumulation of surpluses from meetings over several years to be spei",t on the work of individual special interest groups as detailed in the annual report. In 2020 the Society introduced a nominal membership fee for it's SIGS. The membership fees are designated for the individual special interest groups. ASM The Designated A5M Funds are accumulation of surpluses from meeting5 over several years and are to be spert on education and research. 24
THE BRITISH PAIN SOCIETY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 17 Analysis of net as5et5 between funds Consolidated General Designated Unrestricted Restricted Total Total 2024 Fixed assets Current assets Creditors.. amount5 falling due within one year 1,181 317,779 1,181 520,666 1,181 965,127 202,887 444,461 (95,643) (95,643) (19,855) (115,498) Net 35sets 223,317 202,887 426,204 424,606 850,810 2023 Fixed assets Current assets Creditors.. amountsfalling due within one year 1,879 381,108 1,879 624,064 1,879 1,078 670 242,956 454,606 (132,073) {132,073) (30,000) (162,073) Net assets 250,914 242,956 493,870 424,606 918,47 Charity 2024 Fixed assets Currerit aqsets Creditors.. amounts falling due within one yedl. 1,182 315,318 1,182 518,205 1.18? 962,666 202,887 (94,283) (94,283) (19,855) (J.14, 138) Net assets 222,217 202,887 425,104 424,606 849,710 2023 Fixed assets Curient 055ets Creditors.. umountsfalling due within one year 1,880 377,424 1,880 620,380 1,88LI 1,074,986 242,956 454,606 (129,490) (129,490) (30,000) [159,490) Net a55et5 249.814 242,956 492,770 424,606 917,376 18 Gross obligation5 under operating leasing agreements As at 31 December 2024 the group had future minimum lease commitments B5 follows.. 2024 2023 Total Total Not later than l year Later than l year and not later than 5 years 15,000 13,750 28,750 15,000 28,750 43,750 25
THE BRITISH PAIN SOCIEr NOTE5 TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 19 Reconciliation of net movement in funds to net cash flow from operating artivities Group Charity 2024 2023 2024 2023 Net movement in funds Add back.. depreciation charge Add back.. loss on disposal Interest received Decrease/lincreasel in debtors Increase/ldecreasel in creditors Net cash used in operating activities (67,666) 295 403 (17,828) 10,659 (46,575) (120,712) (13,907) 469 1,360 (18,332) (10,899) 54,579 13,270 (67,666) 295 403 (17,828) 75,119 (45,352) (55,029) (16,375) 469 1,360 (18,332) (68,674) 56,151 (45,401) 20 Finantial instruments Categorisation of financial instruments Group Charity 2024 2023 2024 2023 Financial assets that are debt instrument measured at amortised cost 961,145 115,498 1,074,307 162,073 958,684 114,138 1,070,623 159,490 Financial liabilities measured at amort15ed cost Items of income, expense, gains or losses The total interest income for financial assets not measured at fair value through profit or loss is £17,828 1202.3.. £18.3321. 26